Detalhe da pesquisa
1.
Incident and recurrent hypoglycaemia with linagliptin and glimepiride over a median of 6 years in the CAROLINA cardiovascular outcome trial.
Diabetes Obes Metab
; 25(6): 1453-1463, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36700416
2.
The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non-Asian populations of the EMPA-REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease.
Diabetes Obes Metab
; 24(4): 662-674, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34908223
3.
Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes: A post hoc analysis of pooled data from four phase 3 randomized clinical trials.
Diabetes Obes Metab
; 23(12): 2763-2774, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463415
4.
Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial.
Cardiovasc Diabetol
; 19(1): 150, 2020 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32979921
5.
Effect of Metformin vs. Placebo in Combination with Insulin Analogues on Bone Markers P1NP and CTX in Patients with Type 2 Diabetes Mellitus.
Calcif Tissue Int
; 107(2): 160-169, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32468187
6.
Pooled analysis of Phase III trials indicate contrasting influences of renal function on blood pressure, body weight, and HbA1c reductions with empagliflozin.
Kidney Int
; 93(1): 231-244, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28860019
7.
The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes.
Diabetologia
; 59(9): 1860-70, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27316632
8.
Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study.
Cardiovasc Diabetol
; 14: 11, 2015 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25633683
9.
Impact of empagliflozin on first and recurrent events leading to or prolonging hospitalisation in the EMPA-REG OUTCOME trial.
Diabetes Res Clin Pract
; 212: 111715, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38777127
10.
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Cochrane Database Syst Rev
; (11): CD008143, 2013 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-24214280
11.
Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Cochrane Database Syst Rev
; (4): CD009008, 2013 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23633364
12.
Linagliptin treatment is associated with altered cobalamin (VitB12) homeostasis in mice and humans.
Sci Rep
; 13(1): 601, 2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36635409
13.
Long-term safety and effectiveness of linagliptin by baseline body mass index in Japanese patients with type 2 diabetes: a 3-year post-marketing surveillance study.
Expert Opin Drug Saf
; 21(10): 1303-1313, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35418260
14.
Effects of 18-months metformin versus placebo in combination with three insulin regimens on RNA and DNA oxidation in individuals with type 2 diabetes: A post-hoc analysis of a randomized clinical trial.
Free Radic Biol Med
; 178: 18-25, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34823018
15.
Agreement between fasting and postprandial LDL cholesterol measured with 3 methods in patients with type 2 diabetes mellitus.
Clin Chem
; 57(2): 298-308, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20947697
16.
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Cochrane Database Syst Rev
; (6): CD008143, 2011 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21678374
17.
Effects of anti-diabetes medications on cardiovascular and kidney outcomes in Asian patients with type 2 diabetes: a rapid evidence assessment and narrative synthesis.
Expert Opin Drug Saf
; 20(6): 707-720, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33706621
18.
WITHDRAWN: Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Cochrane Database Syst Rev
; (7): CD008143, 2015 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26222248
19.
WITHDRAWN: Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Cochrane Database Syst Rev
; (7): CD009008, 2015 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26222249
20.
Prediction of carotid intima-media thickness and its relation to cardiovascular events in persons with type 2 diabetes.
J Diabetes Complications
; 34(10): 107681, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32741659